| Software Industry | Information Technology Sector | Fengyou Lu CEO | OTC PINK Exchange | 78468T206 CUSIP |
| US Country | 7 Employees | - Last Dividend | 7 Oct 2013 Last Split | - IPO Date |
Gerpang Healthcare Group is a bio-pharmaceutical company based in Jinan, China, since its inception in 2006. The company specializes in the development, manufacture, and sale of a wide range of bio-pharmaceutical products. With a strong focus on innovation and quality, Gerpang Healthcare Group aims to address various medical and health needs through its diverse portfolio, including genetic coating stents, vaccines, monoclonal antibodies, functional food, and probiotics.
These are advanced medical devices used in the treatment of coronary artery diseases. Genetic coating stents released by Gerpang Healthcare Group are designed to improve the compatibility and efficacy of stent implantations, reducing the risk of complications and promoting faster healing.
Gerpang Healthcare Group has developed vaccines aimed at preventing infection with the Hepatitis B virus. These vaccines are a critical component of public health efforts to reduce the incidence of HBV-related diseases, including chronic hepatitis, cirrhosis, and liver cancer.
These products represent a breakthrough in the diagnosis and treatment of male infertility. Gerpang Healthcare Group's monoclonal antibodies are used to detect specific infertility-related conditions in men, aiding in accurate diagnosis and tailored treatments.
Addressing the growing concern of cognitive disorders, Gerpang Healthcare Group offers functional food products designed to support cognitive health. These foods are enriched with nutrients and compounds that contribute to brain health, potentially improving memory, focus, and other cognitive functions.
The company also deals in polypeptide probiotics, which are aimed at improving gut health and overall well-being. These probiotics are formulated to enhance digestive health, boost the immune system, and provide other health benefits through the modulation of gut flora.